Safety and efficacy of inactivated varicella zoster virus vaccine in immunocompromised patients with malignancies: a two-arm, randomised, double-blind, phase 3 trial
Kathleen M. Mullane(Karolinska University Hospital), P Chilingirov, Shelly McNeil(Dalhousie University), Paula W. Annunziato(Merck & Co., Inc., Rahway, NJ, USA (United States)), Юрий Дмитриевич Иванов, Orla Morrissey(Alfred Health), Shu‐Chih Su(Merck & Co., Inc., Rahway, NJ, USA (United States)), K Oreshkov(Merck & Co., Inc., Rahway, NJ, USA (United States)), AVA Mendes, Luis H. Camacho(St. Luke's Episcopal Hospital), RS Alves, MO Dictar(University of Minnesota), Lionel Duck, B Rabotilova(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jessie Durrand(Merck & Co., Inc., Rahway, NJ, USA (United States)), Mabel Aoun, Velko Minchev, Tatyana Koynova, Ann M. Arvin(Stanford University), J. Thaler(Medical University of Vienna), Thomas Kuehr(Klinikum Wels-Grieskirchen), Susan S. Kaplan(Western Infirmary), F. Franke(Stanford University), Geoffrey Playford(The University of Queensland), Timothy L. Hayes, Che Barrios, S Cerana(Merck & Co., Inc., Rahway, NJ, USA (United States)), Bernard De Prijck(Centre Hospitalier Universitaire de Liège), David M. Ashley(Unknown), Luis Fein(National Cancer Center), JP Tregnaghi, A Radinov, AI Hubenova, Janie Parrino, Manuraj Singh, Bernadette Campbell(Merck & Co., Inc., Rahway, NJ, USA (United States)), R. Greil(Paracelsus Medical University), Petrov Pa(Merck & Co., Inc., Rahway, NJ, USA (United States)), Faith E. Moore(Merck & Co., Inc., Rahway, NJ, USA (United States)), Zoran Popmihajlov(Merck & Co., Inc., Rahway, NJ, USA (United States)), SV Serrano, Rubén Bergel García, Ivan S. F. Chan(United States Military Academy), Martin Pecherstorfer(Wilhelminen Hospital), Vicki A. Morrison(University of Minnesota), JFC Camargo, Koen Van Eygen(Merck & Co., Inc., Rahway, NJ, USA (United States)), Luiz Henrique Barbosa Pires(Merck & Co., Inc., Rahway, NJ, USA (United States)), Pablo Bonvehí
Cited by 36
Related Papers
Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
|New England Journal of Medicine|2012|8k
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
|Clinical Infectious Diseases|2016|2.8k
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
|Clinical Infectious Diseases|2008|2.7k
Invasive Fungal Infections among Organ Transplant Recipients: Results of the Transplant‐Associated Infection Surveillance Network (TRANSNET)
|Clinical Infectious Diseases|2010|1.5k
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
|New England Journal of Medicine|2017|1.2k